FDA’s focus on the quality culture and its request for quality metrics may ensure a successful company-CMO relationship.
Naheed Sayeed-Desta
Advertisement
Articles by Naheed Sayeed-Desta
Advertisement
Latest Updated Articles
Quality Metrics and CMO AgreementPublished: May 15th 2017 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
2
Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care
3
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
4
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
5
